Selzentry (Maraviroc)
Selzentry (Maraviroc)
Selzentry (Maraviroc) is a prescription antiretroviral medication used to treat HIV-1 infection in adults and children aged 2 years and older. It works by blocking the CCR5 receptor on white blood cells, preventing HIV from entering and infecting them. Selzentry is typically taken in combination with other HIV medicines as part of a complete treatment plan to help lower viral load and maintain immune system health.Why Choose Selzentry (Maraviroc)?
- Helps prevent HIV from entering immune cells.
- Reduces viral load when used with other HIV medications.
- Supports immune system strength and function.
- May improve CD4 cell counts over time.
- Available in tablet form for convenient oral use.
How to Use Selzentry (Maraviroc)?
- Take exactly as prescribed by your healthcare provider.
- Usually taken twice daily, with or without food.
- Do not change the dose or stop taking the medication without consulting your doctor.
- Swallow tablets whole, do not crush or chew.
- If you miss a dose, take it as soon as you remember unless it’s close to your next dose.
- Regularly monitor your liver function and viral load as advised by your healthcare provider.
Important Safety Information about Selzentry
- Not recommended for patients with severe kidney or liver impairment without medical supervision.
- Inform your doctor if you have hepatitis B or C, heart problems, or low blood pressure.
- May cause dizziness, avoid driving or operating machinery until you know how it affects you.
- Tell your healthcare provider about all medicines you take, including herbal supplements, as some may interact with Selzentry (e.g., certain antifungals, antibiotics, and antiretrovirals).
- Use only as part of a combination HIV therapy plan.
Fact Table
| Facts | Details |
| Generic Name | Maraviroc |
| Brand Name | Selzentry |
| Drug Class | CCR5 Antagonist / Entry Inhibitor |
| Purpose | Used in combination with other antiretroviral agents to treat HIV-1 infection |
| Mechanism of Action | Blocks the CCR5 co-receptor on CD4 cells, preventing HIV-1 from entering and infecting the cells |
| Route of Administration | Oral |
| Use in Combination Therapy | Always used with other antiretroviral agents as part of combination HIV therapy |
| Onset of Action | Steady-state achieved within 7 days of consistent dosing |
| Contraindications | Hypersensitivity to Maraviroc; severe renal impairment (CrCl <30 mL/min) with concomitant potent CYP3A inhibitors/inducers |
| Precautions | Caution in patients with liver disease, low blood pressure, or heart disease |
| Common Side Effects | Cough, fever, rash, dizziness, abdominal pain, fatigue, muscle or joint pain |
| Drug Interactions | Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin) and inducers (e.g., rifampin, carbamazepine) may alter Maraviroc levels |
| Monitoring Parameters | Liver function tests, renal function, blood pressure, CD4 count, HIV viral load |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light |
| Prescription Status | Prescription only |
| Note | Selzentry is not a cure for HIV infection; adherence to combination therapy and safe practices remains essential |
Common Side Effects
Like all medications, Selzentry (Maraviroc) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.- Cough
- Fever
- Rash or skin irritation
- Stomach pain or bloating
- Dizziness or lightheadedness
How Can You Buy Selzentry (Maraviroc)?
You can order Selzentry (Maraviroc) using these methods on our website:- Order Online
- Order by Phone
- Order by Fax
- Order your refills
